Description: Human liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human liver tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Description: Human liver tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human liver tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated liver tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated liver tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Description: Primary antibody against Liver Canuliculi(HSA98), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Concentration: 0.2mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Concentration: 0.2mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Liver Canuliculi(HSA98), 1mg/mL

Description: Antibody raised against liver Arginase

Description: Antibody raised against liver Arginase

Description: Recombinant Fab monoclonal FABP antibody (liver specific)

Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes.

Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.